{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:36:58Z","timestamp":1790019418813,"version":"4.0.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosom Med"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Depression is associated with an increased risk of mortality in patients with coronary heart disease (CHD). The risk may be reduced in patients who remit with adequate treatment, but few patients achieve complete remission. The purpose of this study was to identify the symptoms that persist despite aggressive treatment for depression in patients with CHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred twenty-five patients with stable CHD who met the DSM-IV criteria for a moderate-to-severe major depressive episode completed treatment with cognitive behavior therapy, either alone or combined with an antidepressant, for up to 16 weeks. Depression symptoms were assessed at baseline and after 16 weeks of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The M (SD) Beck Depression Inventory scores were 30.0 (8.6) at baseline and 8.3 (7.5) at 16 weeks. Seventy seven (61%) of the participants who completed treatment met remission criteria (Hamilton Rating Scale for Depression \u22647) at 16 weeks. Loss of energy and fatigue were the most common posttreatment symptoms both in remitters (<jats:italic toggle=\"yes\">n<\/jats:italic>= 44, 57%;<jats:italic toggle=\"yes\">n<\/jats:italic>= 34, 44.2%) and nonremitters (<jats:italic toggle=\"yes\">n<\/jats:italic>= 42, 87.5%;<jats:italic toggle=\"yes\">n<\/jats:italic>= 35, 72.9%). These symptoms were not predicted by baseline depression severity, anxiety, demographic, or medical variables including inflammatory markers or cardiac functioning or by medical events during depression treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Fatigue and loss of energy often persist in patients with CHD even after otherwise successful treatment for major depression. These residual symptoms may increase the risks of relapse and mortality. Development of effective interventions for these persistent symptoms is a priority for future research.<\/jats:p><\/jats:sec>","DOI":"10.1097\/psy.0000000000000570","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T11:09:57Z","timestamp":1520507397000},"page":"385-392","source":"Crossref","is-referenced-by-count":13,"title":["Residual Symptoms After Treatment for Depression in Patients With Coronary Heart Disease"],"prefix":"10.1097","volume":"80","author":[{"given":"Robert M.","family":"Carney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Steinmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene H.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230824","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"bib2-20230824","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","article-title":"Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"bib3-20230824","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"bib4-20230824","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"bib5-20230824","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/PSY.0000000000000332","article-title":"A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): results of an observer-blinded, multicenter, randomized trial in depressed patients with coronary artery disease","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib6-20230824","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.106.028647","article-title":"Effects of antidepressant treatment following myocardial infarction","volume":"190","year":"2007","journal-title":"Br J Psychiatry"},{"key":"bib7-20230824","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.psy.0000133362.75075.a6","article-title":"Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study","volume":"66","year":"2004","journal-title":"Psychosom Med"},{"key":"bib8-20230824","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1176\/appi.ajp.2007.06091492","article-title":"Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events","volume":"164","year":"2007","journal-title":"Am J Psychiatry"},{"key":"bib9-20230824","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archgenpsychiatry.2009.121","article-title":"Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants","volume":"66","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"bib10-20230824","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9149(01)01675-7","article-title":"Even minimal symptoms of depression increase mortality risk after acute myocardial infarction","volume":"88","year":"2001","journal-title":"Am J Cardiol"},{"key":"bib11-20230824","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/hc0902.104707","article-title":"Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction","volume":"105","year":"2002","journal-title":"Circulation"},{"key":"bib12-20230824","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","year":"2006","journal-title":"Am J Psychiatry"},{"key":"bib13-20230824","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0b013e31820ebd2c","article-title":"Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication","volume":"31","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"bib14-20230824","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4088\/JCP.v60n0403","article-title":"Residual symptoms in depressed patients who respond acutely to fluoxetine","volume":"60","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 2","key":"bib15-20230824","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.12084su1c.02","article-title":"Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances","volume":"74","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"bib16-20230824","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"bib17-20230824","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","year":"2011","journal-title":"Psychol Med"},{"key":"bib18-20230824","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S0033291701004214","article-title":"Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up, 1981\u20131994","volume":"31","year":"2001","journal-title":"Psychol Med"},{"key":"bib19-20230824","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0327(98)00138-4","article-title":"Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse","volume":"50","year":"1998","journal-title":"J Affect Disord"},{"key":"bib20-20230824","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/appi.ajp.157.9.1501","article-title":"Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?","volume":"157","year":"2000","journal-title":"Am J Psychiatry"},{"key":"bib21-20230824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","year":"2010","journal-title":"Psychol Med"},{"key":"bib22-20230824","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2015.09.005","article-title":"What are 'good' depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis","volume":"189","year":"2016","journal-title":"J Affect Disord"},{"key":"bib23-20230824","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamapsychiatry.2015.2079","article-title":"Association of Symptom Network Structure With the Course of [corrected] Depression","volume":"72","year":"2015","journal-title":"JAMA Psychiat"},{"key":"bib24-20230824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PSY.0000000000000245","article-title":"Cardiac risk markers and response to depression treatment in patients with coronary heart disease","volume":"78","year":"2016","journal-title":"Psychosom Med"},{"key":"bib25-20230824","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2016.04.051","article-title":"Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease","volume":"200","year":"2016","journal-title":"J Affect Disord"},{"key":"bib26-20230824","first-page":"897","article-title":"The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity","volume":"64","year":"2002","journal-title":"Psychosom Med"},{"key":"bib28-20230824","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"bib29-20230824","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","year":"1989","journal-title":"Psychiatry Res"},{"key":"bib30-20230824","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1080\/02701367.2000.11082794","article-title":"Assessment of physical activity: an international perspective","volume":"71","year":"2000","journal-title":"Res Q Exerc Sport"},{"key":"bib32-20230824","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"bib33-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","year":"2014","journal-title":"J Affect Disord"},{"key":"bib35-20230824","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jamainternmed.2015.5220","article-title":"Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial","volume":"175","year":"2015","journal-title":"JAMA Intern Med"},{"key":"bib36-20230824","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archgenpsychiatry.2009.7","article-title":"Treatment of depression after coronary artery bypass surgery: a randomized controlled trial","volume":"66","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"bib40-20230824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-clinpsy-050212-185608","article-title":"Network analysis: an integrative approach to the structure of psychopathology","volume":"9","year":"2013","journal-title":"Annu Rev Clin Psychol"},{"key":"bib41-20230824","first-page":"1","article-title":"Network analysis of depression and anxiety symptom relationships in a psychiatric sample","volume":"46","year":"2016","journal-title":"Psychol Med"},{"key":"bib43-20230824","doi-asserted-by":"crossref","first-page":"e90311","DOI":"10.1371\/journal.pone.0090311","article-title":"The impact of individual depressive symptoms on impairment of psychosocial functioning","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib44-20230824","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1017\/S0033291714000063","article-title":"Cognitive\/affective and somatic\/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis","volume":"44","year":"2014","journal-title":"Psychol Med"},{"key":"bib45-20230824","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpsychores.2009.07.013","article-title":"Depressive symptoms in persons with acute coronary syndrome: specific symptom scales and prognosis","volume":"68","year":"2010","journal-title":"J Psychosom Res"},{"key":"bib46-20230824","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1600-0447.2001.103002122.x","article-title":"Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)","volume":"103","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"bib47-20230824","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"bib48-20230824","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/2047487312436452","article-title":"Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry","volume":"20","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"bib49-20230824","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archgenpsychiatry.2010.36","article-title":"Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome","volume":"67","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"bib50-20230824","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4088\/JCP.v68n0211","article-title":"A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder","volume":"68","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"bib51-20230824","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2008.06.021","article-title":"Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial","volume":"169","year":"2009","journal-title":"Psychiatry Res"},{"key":"bib52-20230824","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.biopsych.2005.03.030","article-title":"Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?","volume":"57","year":"2005","journal-title":"Biol Psychiatry"},{"key":"bib53-20230824","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2011.12.015","article-title":"Symptom specificity in the acute treatment of major depressive disorder: a re-analysis of the treatment of depression collaborative research program","volume":"137","year":"2012","journal-title":"J Affect Disord"},{"key":"bib54-20230824","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/PSY.0000000000000423","article-title":"Vital exhaustion and coronary heart disease risk: a systematic review and meta-analysis","volume":"79","year":"2017","journal-title":"Psychosom Med"},{"key":"bib55-20230824","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.psy.0000151485.38411.36","article-title":"Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT)","volume":"67","year":"2005","journal-title":"Psychosom Med"},{"key":"bib56-20230824","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1249\/01.MSS.0000125997.63493.13","article-title":"Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial","volume":"36","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"bib57-20230824","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10880-008-9105-z","article-title":"Exercise and depression: a review of reviews","volume":"15","year":"2008","journal-title":"J Clin Psychol Med Settings"},{"key":"bib58-20230824","first-page":"CD004366","article-title":"Exercise for depression","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"bib59-20230824","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00007256-200939060-00004","article-title":"The antidepressive effects of exercise: a meta-analysis of randomized trials","volume":"39","year":"2009","journal-title":"Sports Med"},{"key":"bib60-20230824","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jad.2015.08.057","article-title":"The association between cardiac rehabilitation and mortality risk for myocardial infarction patients with and without depressive symptoms","volume":"188","year":"2015","journal-title":"J Affect Disord"},{"key":"bib61-20230824","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.amjmed.2007.03.026","article-title":"Impact of cardiac rehabilitation on depression and its associated mortality","volume":"120","year":"2007","journal-title":"Am J Med"},{"key":"bib62-20230824","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jamainternmed.2015.3006","article-title":"Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis","volume":"175","year":"2015","journal-title":"JAMA Intern Med"},{"key":"bib63-20230824","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2011.03.013","article-title":"Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?","volume":"35","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006842-201805000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:38:59Z","timestamp":1751470739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006842-201805000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000000570","relation":{},"ISSN":["1534-7796","0033-3174"],"issn-type":[{"value":"1534-7796","type":"electronic"},{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}